Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 182   

Articles published

PFE 29.11 +0.51 (1.78%)
price chart
Pfizer Approves $11 Bln Share Buyback, Dividend; Wins Sutent Patent Case
The company also said that a U.S. court has ruled in its favor in a patent lawsuit filed against generic drug maker Mylan Inc. ( MYL ) related to Pfizer's cancer drug Sutent. Pfizer's board authorized the new $11 billion share repurchase program to be ...
Should Pfizer Inc. Buy Actavis plc?
Earlier this year, a media circus erupted over Pfizer's reported interest in AstraZeneca (NYSE: AZN ) . The deal would have exceeded $100 billion and created a company roughly the same size as Johnson & Johnson. AstraZeneca brass, however, felt the ...
Pfizer Inc. May Be Interested In Buying Actavis plc [REPORT]  ValueWalk
Pfizer Inc. Is Kicking The Tires At Actavis PLC  Benzinga
Related articles »  
Pfizer Results Will Play Second Fiddle to Dealmaking Outlook -- Earnings Preview
Pfizer Inc. is scheduled to announce its third-quarter earnings Tuesday morning. Here's what you need to know: EARNINGS FORECAST: Net income of 55 cents a share is the consensus of analysts surveyed by Thomson Reuters, compared with 58 cents ...
Pfizer Now #16 Largest Company, Surpassing AT&T
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock. Many beginning ...
Related articles »  
American Express Company (AXP), Wells Fargo & Co (WFC), Pfizer Inc. (PFE ...
After mostly reducing his exposure to Pfizer Inc. (NYSE:PFE) during the last several years, Mr. Fisher started again to increase his holding in the company.
Related articles »  
Pfizer (PFE) $11B Stock Repurchase Plan May End AstraZeneca (AZN) Bid
NEW YORK (TheStreet) -- Shares of Pfizer Inc (PFE) are climbing, up 1.68% to $29.08 in midday trading, after the U.S. drug maker announced late yesterday that it will continue buying back stock, deflating expectations that it will make a new bid to buy ...
Trade-Ideas: Pfizer (PFE) Is Today's Pre-Market Leader Stock
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products.
Related articles »  
Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
PCSK9 inhibitors, and their potential sales, have garnered a lot of interest from investors Pfizer's (NYSE: PFE ) Lipitor peaked at well over $10 billion in annual sales.
One Put, One Call Option To Know About for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Pfizer Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Related articles »  
Pfizer approves $US11bn repurchase plan
DRUGMAKER Pfizer has approved the repurchase of $US11 billion ($A11.9 billion) in company stock. THE New York company didn't say when it would buy back the shares. Pfizer has $US1.3 billion remaining from its latest stock repurchase program.